Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Xeloda – Treatment for Metastatic Colorectal Cancer

Drug (brand / generic)

Xeloda / Capecitabine

Company / Licensee

Roche

Therapy Class

Antimetabolite

Product Description

Fluoropyrimidine carbamate with antineoplastic activity

Current Indication

Metastatic colorectal cancer and breast cancer

Market Sector

Oncology

Development Status

Approved (US and EU)
Expand
Close
Close
Close

Go Top